Communication : Oncology Times

An abstract is unavailable.

Source: LWW

Categories: Hem/Onc News and Journals

Tags: cancer

Tweets with this article

Oncology Times

What are the barriers to effective communication in #cancer care and how can these be addressed? @BrianBolwellMD outlines useful strategies: https://t.co/8Pd1MLxFMN #tuesdaymotivation #health via @ClevelandClinic https://t.co/cebhvxCG3t

FDA Updates Highlighting the Latest Cancer Treatments : Oncology Times

An abstract is unavailable.

Oncology Times December 21, 2024

Obesity-Related Cancer Risk in Newly Diagnosed Type 2… : Oncology Times

An abstract is unavailable.

Oncology Times December 21, 2024

Ziftomenib Shows Promise in Treatment-Resistant AML : Oncology Times

An abstract is unavailable.

Oncology Times December 20, 2024

How Generational Status Affects Risk of Prostate Cancer in… : Oncology Times

An abstract is unavailable.

Oncology Times December 20, 2024

Landmark Clinical Trial Shows Value of Immunotherapy for… : Oncology Times

An abstract is unavailable.

Oncology Times December 20, 2024

View From the Other Side of the Stethoscope: Simone Biles’… : Oncology Times

An abstract is unavailable.

Oncology Times December 19, 2024

mRNA Vaccine Candidate Shows Promise in Fight Against… : Oncology Times

An abstract is unavailable.

Oncology Times December 19, 2024

UpToDate® : Oncology Times

An abstract is unavailable.

Oncology Times December 19, 2024

The Use of HCT for Hematologic Cancers Across Patient Groups : Oncology Times

An abstract is unavailable.

Oncology Times December 19, 2024

Responses to immune checkpoint inhibitor therapy in NF1 mutated cutaneous melanoma.

We present data on radiographic responses to ICI therapy in advanced melanoma patients with tumors harboring NF1 (Neurofibromatosis 1) mutations.

Oncology Times December 18, 2024

Related Articles